Todas las categorías
| Product Name | Descripción | Action |
|---|---|---|
| Concizumab ,Alhemo ,TFPI ,Anticuerpo Monoclonal ,No. CAS 1312299-39-0 | Trade Name : Alhemo Target : TFPI Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 200~500(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Durvalumab, Imfinzi, PD-L1, MEDI4736, Inhibidor de puntos de control inmunitario anti-PD-L1, Inmunoterapia oncológica / Biológico de inmunoterapia contra el cáncer, Infusión intravenosa, Anticuerpo monoclonal, N.º CAS 1428935-60-7 | Trade Name : Imfinzi Target : PD-L1 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 5900(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Emicizumab, Hemlibra, Factor IXa (FIXa) y Factor X (FX), ACE910, Anticorpo monoclonal bispecífico, Anticorpo IgG4 humanizado, Anticorpo monoclonal, No CAS 1610943-06-0 | Trade Name : Hemlibra Target : Factor IXa (FIXa) and Factor X (FX) Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 2421(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this ... |
|
| Donanemab, Kisunla, N3pG-amiloide β, LY3002813, Neurología biológica / Biología de la enfermedad de Alzheimer, Terapia modificadora de la enfermedad, Anticorpos monoclonales, CAS no.1931944-80-7 | Trade Name : Kisunla Target : N3pG-amyloid β Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 800~1200(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us.... |
|
| Benralizumab, Fasenra, IL-5Rα, MEDI-563, Biológico del receptor anti-IL-5, Biológico respiratorio / Biológico del asma, Anticorpo monoclonal, No CAS 1044511-01-4 | Trade Name : Fasenra Target : IL-5Rα Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 920(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us... |
|
| Lecanemab | Trade Name : Leqembi Target : Amyloid-β (Aβ) Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 500(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Faricimab, Vabysmo, VEGF/ANGPT2, RG7716, Anticuerpo monoclonal biespecífico, Biológico anti-VEGF/anti-Ang-2, Anticuerpo biespecífico, N.º CAS 1607793-29-2 | Trade Name : Vabysmo Target : VEGF/ANGPT2 Molecular Type : Bispecific Antibody Sales in 2025 (Millions of USD) : 4300 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Brentuximab vedotina,Adcetris,CD30,SGN-35,ADC de Oncología / ADC de linfoma de Hodgkin / ADC de ALCL,no CAS 914088-09-8 | Trade Name : Adcetris Target : CD30 Molecular Type : ADC Sales in 2025 (Millions of USD) : 1800~1900(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
